Vitamin B12 identified as the inhibitor of a key enzyme in hereditary Parkinson’s disease
Vitamin B12 significantly prevents the neurotoxicity of LRRK2 genetic variants associated with hereditary Parkinson’s disease. The findings may help with the development of new therapies to combat the neurodegenerative disease.
Source
Author: neurosciencenews – robotics
Date/time: 5th April 2019, 03:02